21st Cancer Patient Day at the NCT Heidelberg on March 14
The National Center for Tumor Diseases (NCT) Heidelberg invites you to its 21st Cancer Patient Day on March 14. The Patient Day offers easy-to-understand specialist lectures, expert forums on specific types of cancer, and plenty of opportunities for personal discussions. As usual, numerous self-help groups and partners of the NCT Heidelberg will be represented with information stands for patients, relatives, and anyone interested. Registration is possible until March 10 at this link: https://indico.dkfz.de/e/Krebspatiententag2026
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the Heidelberg University Hospital (UKHD), the Heidelberg Medical Faculty of the Heidelberg University and the Thoraxklinik Heidelberg.
The 21st Cancer Patient Day at the NCT Heidelberg provides patients, relatives, and anyone interested with first-hand information on current developments in oncology. Participants can talk directly to experts and the active self-help network. Cancer Patient Day will take place on March 14, 2026, from 9 a.m. to 2:30 p.m. at the Surgical and Medical Clinic at Heidelberg University Hospital. The presentations will also be broadcast live online.
In the morning, guests can attend informative presentations on the latest findings in research and therapy, as well as on support services in oncology. Self-help groups and patient representatives at the NCT Heidelberg will also introduce themselves. Afterwards, experts from the NCT Heidelberg's counseling services will be available to answer individual questions and talk to those affected.
The expert forums in the afternoon will provide an opportunity for direct exchange with medical professionals and representatives of self-help groups – organized according to specific diseases, with time for specific concerns. During the Cancer Patient Day, visitors can also visit information stands and talk to many self-help groups and other partners about coping with the disease.
Registration for the 21st Cancer Patient Day at the NCT Heidelberg is open until March 10 online at this link: https://indico.dkfz.de/e/Krebspatiententag2026
+++
Media representatives are welcome to attend Cancer Patient Day. Please register by emailing Martin Staiger at martin.staiger(at)nct-heidelberg.de. See below for further contact details.
+++
Specialist presentations
- Dr. Christoph Grott: Radiation Therapy
- Dr. Maria-Veronica Teleanu: Molecular Oncology
- Prof. Dr. Rosa Klotz: Oncological surgery
- Prof. Dr. Dirk Jäger: Immunotherapy
- PD Dr. Bettina Thomas, Prof. Dr. Dr. Guy Ungerechts: Clinical studies
- Anne Weininger: Counseling services
Over coffee with the counseling services
- Nutritional therapy
- Integrative oncology
- Hospital chaplaincy
- Oncological sports and exercise therapy
- Palliative medicine
- Psycho-oncological counseling and treatment
- Social services
Expert forums
- Breast cancer
- Gynecological tumors
- Tumors of the prostate, bladder, kidneys, testicles, and penis
- Cancer of the digestive organs, endocrine and neuroendocrine tumors
- Head and neck tumors
- Brain tumors
- Lung cancer and tumors of the chest
- Blood cancer and cancer of the blood-forming systems (leukemia, lymphoma, and multiple myeloma)
- Bone and soft tissue tumors (sarcomas), cancers with unknown primary tumor (CUP)
- Skin cancer
Registration information and contact details
21st Cancer Patient Day at the NCT Heidelberg
March 14, 2026
9 a.m. to 2:30 p.m.
Heidelberg University Hospital
Surgical Clinic and Medical Clinic (Krehl Clinic)
Register online by March 10 at https://indico.dkfz.de/e/Krebspatiententag2026
For safety reasons, space is limited. Participation is free of charge. Refreshments and snacks will be provided.
National Center for Tumor Diseases (NCT) Heidelberg
Training and Events
Phone: (06221) 56-36091
Email: nct.events@nct-heidelberg.de
Organizer: Heidelberg University Hospital
Donations
Donations to cover costs are welcome.
Account: 7 421 500 429
Bank: BW-Bank Stuttgart
IBAN: DE64 6005 0101 7421 5004 29
BIC: SOLADEST600
Purpose: D.10081910 / Patient Day 2026
An image accompanying this press release is available free of charge at:
Terms of use for images accompanying press releases
Use is free of charge. The NCT Heidelberg permits one-time use in connection with reporting on the topic of the press release. Please cite the copyright “NCT Heidelberg/Marius Stark” as the image credit. The image material may only be passed on to third parties after prior consultation with NCT Communications (tel.: +49 6221 42-56311272, email: martin.staiger@nct-heidelberg.de). Use for commercial purposes is prohibited.
Press contact:
Dr. Martin Staiger
National Center for Tumor Diseases (NCT) Heidelberg
Communications and Events
Im Neuenheimer Feld 460
69120 Heidelberg, Germany
Tel.: +49 6221 56-311272
Email: martin.staiger(at)nct-heidelberg.de
www.nct-heidelberg.de
The National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the University Hospital Heidelberg (UKHD), the Heidelberg Medical Faculty of the Heidelberg University and the Thoraxklinik Heidelberg. The aim of the NCT Heidelberg is to transfer promising approaches from cancer research into clinical practice as quickly as possible, and thus to benefit patients. This applies to both diagnosis and treatment, in aftercare or prevention. Participation in clinical studies opens up access to innovative therapies. The NCT Heidelberg is thus a leader in transferring new research results from the laboratory to the clinic The NCT Heidelberg, founded in 2004, is part of the NCT with further locations in Berlin, Dresden, SouthWest (Tübingen-Stuttgart/Ulm), WERA (Würzburg, Erlangen, Regensburg, Augsburg) and West (Essen/Cologne).
German Cancer Research Center (DKFZ)
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.
To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:
- National Center for Tumor Diseases (NCT, 6 sites)
- German Cancer Consortium (DKTK, 8 sites)
- Hopp Children's Cancer Center (KiTZ) Heidelberg
- Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
- DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
- National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Research, Technology and Space and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.
Heidelberg University Hospital and Faculty of Medicine: Internationally Renowned Patient Care, Research and Teaching
Heidelberg University Hospital (Universitätsklinikum Heidelberg, UKHD) is one of the largest and most prestigious medical centers in Germany. The Medical Faculty of Heidelberg University (Medizinische Fakultät Heidelberg, MFHD) belongs to the internationally renowned biomedical research institutions in Europe. Both institutions have the common goal of developing new therapies and implementing them rapidly for patients. Heidelberg University Hospital and the Medical Faculty of Heidelberg University employs around 14.500 employees and is committed to providing trainings and qualifications. Every year, around 86,000 patients and more than 1.100.000 outpatient cases are treated in more than 50 clinical departments with almost 2.500 beds.
Together with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the German Cancer Aid, the UKHD established the first National Center for Tumor Diseases (NCT) in Heidelberg. The goal is to provide care at the highest level as an oncology center of excellence and to rapidly transfer promising approaches from cancer research to the hospital. In addition, the UKHD operates in partnership with the DKFZ and the University of Heidelberg the Hopp Children’s Cancer center Heidelberg (KiTZ), a unique and nationally known therapy and research center for oncological and hematological diseases in children and adolescents.
The Heidelberg Curriculum Medicinale (HeiCuMed) is one of the top medical training programs in Germany. Currently, there are about 4.000 future physicians studying in Heidelberg.